Table 1.
Anthropometric data of patients with Post-COVID-19 Syndrome (PCS) and control groups.
| PCS (n = 103) |
CAD (n = 103) |
Ctrl (n = 90) |
p-value | |
|---|---|---|---|---|
| Age, years | 49.0 ± 11.3 | 54.9 ± 7.0 | 43.7 ± 10.7 | < 0.0001# |
| Sex, n (%) | < 0.0001§ | |||
| Female | 44 (45.7) | 13 (12.6) | 12 (13.3) | |
| Male | 59 (57.3) | 90 (87.4) | 78 (86.7) | |
| Height, cm | 173.5 ± 9.4 | 176.7 ± 8.6 | 169.1 ± 8.6 | < 0.0001# |
| Weight, kg | 93.1 ± 24.0 | 92.8 ± 17.2 | 74.6 ± 16.1 | < 0.0001* |
| BMI, kg*m−2 | 30.8 ± 6.7 | 29.6 ± 4.5 | 26.1 ± 5.4 | < 0.0001* |
Data presented as mean ± SD or n (%). Between-group comparison was performed using one-way ANOVA with Tukey's multiple comparisons test or Kruskal–Wallis test. #Significantly different for PCS vs. CAD, PCS vs. CG and CAD vs. CG; *Significantly different for PCS vs. CG and CAD vs. CG; §Significantly different for CG vs. PCS and CAD. PCS, Post-Covid Syndrome patients; CAD, Coronary Artery Disease patients. Crtl, healthy control group.